About CAR-T leukemia therapy, part of a new wave in cancer treatment – ABC News
Chicago Tribune |
About CAR–T leukemia therapy, part of a new wave in cancer treatment
ABC News The committee’s approval for CAR–T therapy applies to children and young adults, ages 3 to 25, with a form of leukemia called relapsed or refractory B-cell acute lymphoblastic leukemia (ALL). ALL is the most common type of cancer in children, with … First gene therapy — ‘a true living drug’ — on the cusp of FDA approvalChicago Tribune Novartis CAR–T Therapy Drug Recommended by FDA PanelNasdaq FDA may approve goundbreaking cancer treatment that uses body’s immune system to fight diseaseThe Independent Fortune –Gizmodo –FDA –New York Times all 245 news articles » |
Popular Science |
Why CAR T-cell immunotherapy is such a big deal for cancer treatment
Popular Science The treatment is known in the medical community as CAR T-cell therapy. It involves removing some T-cells—a type of white blood cell—from a patient’s blood. Then researchers tweak the outside of each cell in the lab by adding a receptor called CAR … CAR–T gene therapy for leukemia clears FDA hurdleCBS News A New Dawn: First CAR T Cell Recommended for FDA ApprovalMedscape FDA Panel Unanimously Recommends Approval for Novartis’ CAR T-Cell Therapy CTL019Genetic Engineering & Biotechnology News Washington Post –FierceBiotech –ABC News –FDA all 163 news articles » |
Motley Fool |
Loving Prime Day, Fighting a Duopoly, and Getting Hip to CRISPR
Motley Fool And we’re going to talk about CRISPR, and the first thing we’ll do with CRISPR is explain what CRISPR is. Some of you may already know. I was completely in the dark on this. But, let’s start with Prime Day. This is dominating the business media today … |